# FDA Inspection 1226886 - Basilea Pharmaceutica International - December 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/basilea-pharmaceutica-international/8b31254c-d76d-4bb8-8e1d-4fc5114fee7b
Source feed: FDA_Inspections

> FDA Inspection 1226886 for Basilea Pharmaceutica International on December 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226886
- Company Name: Basilea Pharmaceutica International
- Inspection Date: 2023-12-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/basilea-pharmaceutica-international/4ac1c9d7-0c1c-40b2-9f0e-2e1697e7c6a9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c